Search alternatives:
significantly predicted » significantly reduced (Expand Search), significantly reduce (Expand Search), significant predictor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
predicted decrease » predicted secreted (Expand Search), reported decrease (Expand Search)
significantly predicted » significantly reduced (Expand Search), significantly reduce (Expand Search), significant predictor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
predicted decrease » predicted secreted (Expand Search), reported decrease (Expand Search)
-
2401
-
2402
-
2403
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2404
-
2405
-
2406
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2407
-
2408
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2409
-
2410
-
2411
-
2412
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2413
-
2414
-
2415
-
2416
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2417
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2418
-
2419
-
2420
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: